Pharmaceuticals
14 articles
Cassidy bill proposes changes to 340B drug discount program
In 2023, the 340B drug discount program recorded a record high of $66.
How to Trust Generic Drugs: Efficacy, Savings, and Informed Choices
A recent nationwide study in India delivered a powerful message: every single one of 131 generic medicine samples, spanning 22 essential categories, met all quality criteria.
FDA Pilot Program Accelerates Clinical Trials for Faster Drug Approvals
The FDA is now aiming to cut up to a year from early-stage clinical trials, following a recent decision to reduce required trials for drug approval from two to one.
Novo Nordisk security breach exposes patient data in cyberattack
Patient data, including sensitive medical histories from some of Novo Nordisk's clinical trials, was compromised in a recent cybersecurity breach.
Trump administration plan could weaken Medicare drug price negotiation
In 2024, Medicare spent $125 billion on just 40 drugs, representing over one-third (36%) of its total drug budget, according to KFF .
Boehringer Ingelheim drug slashes liver and belly fat
In Phase 3 trials, Boehringer Ingelheim's experimental obesity drug, survodutide, helped recipients shed up to 17% of their body weight over 76 weeks, crucially preserving muscle mass.
Medicare offers $50 monthly GLP-1 access amid obesity drug competition
Starting July 1, 2026, eligible Medicare beneficiaries will pay just $50 a month for certain GLP-1 obesity drugs.
Lilly's oral obesity drug shows promising safety and tolerability
Lilly's experimental oral obesity drug, aleniglipron, helped patients lose up to 12.
AI Drug Development Surges: In Silico Trials Market Grows Dramatically
Biotech firm Insilico Medicine used artificial intelligence to discover a novel drug candidate for idiopathic pulmonary fibrosis (IPF) and advance it to Phase I clinical trials in under 30 months, acc
Legend Biotech stock surges on strong Q1 CAR T-cell therapy results
Legend Biotech's stock recently jumped 42% following new data, propelled by early clinical successes in difficult-to-treat cancers and robust sales of its existing CAR-T therapy, CARVYKTI, according t
Alnylam partners with Inceptive Nucleics for AI-driven RNAi therapeutics
Alnylam Pharmaceuticals, a leader in RNAi therapeutics, just committed $30 million upfront and up to $2 billion to Silicon Valley biotech startup Inceptive Nucleics.
Pfizer partners with Innovent Biologics for drug pipeline
Pfizer has committed up to $10.5 billion to a collaboration with Innovent Biologics in China to advance a pipeline of 12 novel therapies.
Trump Drug Pricing Deals Face Test as New Drugs Launch
The Medicare negotiated price for semaglutide, the active ingredient in blockbuster drugs like Ozempic, is $274 under the Inflation Reduction Act.
Merck Halts Parkinson's Drug Program After Phase 3 Setback
Merck's Parkinson's drug, preladenant, was discontinued in 2026 after Phase 3 trials showed it was no more effective than a placebo.